Ascend Wellness Holdings, Inc. last reported quarterly results on Aug 12, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $126.1 million (-0.9% year over year) and diluted EPS of -$0.05. It usually reports 40–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 9, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Monday. Based on last year's release for the same quarter on Nov 10, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 40–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 12, 2026
43 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
126
-0.9%
|
-10
+59.8%
|
-0.05
+58.3%
|
|
May 13, 2026
43 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
117
-8.6%
|
-29
-53.1%
|
-0.15
-66.7%
|
|
Feb 9, 2026
40 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
121
-11.4%
|
-49
-190.1%
|
-0.24
-206.2%
|
|
Nov 10, 2025
41 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
125
-11.9%
|
-26
+8.6%
|
-0.13
+0.0%
|
|
Aug 7, 2025
38 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
127
-10.1%
|
-24
-12.0%
|
-0.12
-20.0%
|
|
May 12, 2025
42 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
128
-10.1%
|
-19
-6.0%
|
-0.09
+0.0%
|
|
Mar 12, 2025
71 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
136
-3.0%
|
-17
+13.2%
|
-0.08
+15.9%
|
|
Nov 12, 2024
43 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
142
+0.3%
|
-28
-151.4%
|
-0.13
-160.0%
|
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- AAWH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochelle Park, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1756390
- Former names
- Ascend Wellness Holdings, Inc (until Mar 11, 2022); Ascend Wellness Holdings, LLC (until Apr 15, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.